Vitae Pharma Cash Flow - Annual (NASDAQ:VTAE)

Add to My Stocks
$21 $0 (0%) VTAE stock closing price Oct 25, 2016 (Closing)

The Vitae Pharma cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Vitae Pharma profits and Vitae Pharma debt. Vitae Pharma saw a cash impact of $37.93M from the issuance of VTAE shares. The cash flow statement helps in the Vitae Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Vitae Pharma has a negative cash and cash equivalents change of $-17.72M.

View details of Vitae Pharma cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2015201420132012
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----
Net Increase (Decrease) in Assets Liabilities3.16M-1.11M10.7M-10.72M
Cash From (used in) Discontinued Operations----
Other Adjustments Net2.51M1.94M-0.15M-0.08M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.29M-0.25M-0.17M-0.12M
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments-11.76M-24.56M5.85M-3.38M
Other Cash Inflow (Outflow) from Investment Activities----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares37.93M58.88M--
Issuance (Repayment) of Debt Securities-4.93M-5.46M-4.6M-
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities-0.62M-2.41M--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year29.49M21.15M7.62M20.95M
Cash & Equivalents at Year End11.77M29.49M21.15M7.62M
All figures in USD. M: Millions of USD, B: Billions of USD.

Vitae Pharma stock comparison chart provides an easy way to compare the stock price with peers along with details of Vitae Pharma stock price history.
The statement of cash flows can be categorized into three main sections:

  • Vitae Pharma saw a negative change in Net Change in Cash and Cash Equivalents of $-17.72M in 2015. Apart from the Vitae Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Vitae Pharma lost $-38.03M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: Vitae Pharma used $-12.06M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $32.37M for Vitae Pharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Annual Cash Flow Statements For Vitae Pharmaceuticals Inc Peers

Biogen Inc cash flow, ChemoCentryx cash flow, GlycoMimetics cash flow, Merck cash flow